Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma.
In: Journal of Clinical Oncology, Jg. 32 (2014-11-10), Heft 32, S. 3659-3669
Online
academicJournal
Zugriff:
Titel: |
Phase I/II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Patients With Advanced Melanoma.
|
---|---|
Autor/in / Beteiligte Person: | Ott, Patrick A. ; Hamid, Omid ; Pavlick, Anna C. ; Kluger, Harriet ; Kim, Kevin B. ; Boasberg, Peter D. ; Simantov, Ronit ; Crowley, Elizabeth ; Green, Jennifer A. ; Hawthorne, Thomas ; Davis, Thomas A. ; Sznol, Mario ; Hwu, Patrick |
Link: | |
Zeitschrift: | Journal of Clinical Oncology, Jg. 32 (2014-11-10), Heft 32, S. 3659-3669 |
Veröffentlichung: | 2014 |
Medientyp: | academicJournal |
ISSN: | 0732-183X (print) |
DOI: | 10.1200/JCO.2013.54.8115 |
Sonstiges: |
|